Siftome Phase 3L

GSE123762

The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq]

Not suitable Dataset does not meet the current suitability threshold.
Sample grouping CSV Contrast CSV DESeq2 metadata CSV R handoff notes Handoff report Download instructions Open GEO dataset
Source
GEO
Search intent
Patient tissue tumor-vs-normal
Intent behavior
search-intent-behavior-v1
Submission date
2018-12-13
Last update
2021-01-26
Organization
Flinders University
Department
College of Medicine and Public Health
Public date
2021-01-18
Experiment types
Expression profiling by high throughput sequencing
Platforms
GPL16791 Illumina HiSeq 2500 (Homo sapiens)
Series type
SubSeries
SubSeries
Not available
BioProject
PRJNA509777
Supplementary files
XLSX: GSE123762_Invasive_breast_cancer_E_v_ED_normalised_expression_RPKM.xlsx; XLSX: GSE123762_Normal_breast_E_v_ED_combined_expression_RPKM.xlsx
Organism
Homo sapiens
Assay
bulk RNA-seq
Samples
50
Study design
Tumor vs unmatched normal
Specimen/source
Tissue
Scoring version
intent-aware-scoring-v15
Ranking batch
b69568dd1e4fe1b9ee2d880bf5495d748a7e4c5c11e4107f02528c3be0e76012
Ranking created
2026-06-05T20:20:27.088676Z
Warning version
intent-aware-warnings-v2

Current Intent Interpretation

Patient tissue tumor-vs-normal

Expectations

Organism
Homo sapiens
Assay
bulk RNA-seq
Specimen/source
patient tissue or biopsy
Controls
matched normal, adjacent normal, paired normal, healthy tissue control, or otherwise normal tissue control

Rules

Default filters
Human only; Bulk RNA-seq only; Tumor-normal only; Tissue or biopsy only; Hide biofluid/model systems
Warning rules
missing or unclear control group, unclear disease context, unclear tissue source, mixed sample types, model-system markers, secondary assay context, missing processed data, or small cohort size
Score caps
non-human datasets stay below the primary recommendation band, missing colorectal/colon/rectal/CRC context stays below the primary recommendation band, biofluid and model-system datasets cannot reach Recommended by default, microarray and secondary assays are capped unless explicitly enabled, or small cohorts are capped below high-confidence recommendations
Downgraded contexts
microarray unless explicitly enabled, biofluid-only datasets, cell-line datasets, organoid datasets, xenograft or PDX datasets, non-colorectal disease contexts, or treatment-only experiments

Study Classification

Tumor vs unmatched normal Tissue

Analysis Readiness

Ready after review
100% DE readiness

Contrast completeness

25/25 pts

Both case and control groups are present in the proposed grouping.

Minimum group size

20/20 pts

Each contrast group has at least 2 samples.

Processed data availability

20/20 pts

Processed data is marked available in the GEO index.

Sample decision clarity

15/15 pts

All samples are assigned to a case or control group.

Blocking warnings

10/10 pts

No dataset warnings are present.

Metadata normalization

10/10 pts

Metadata quality is high enough to support downstream handoff.

Blockers

No readiness blockers detected.

Next Steps

  • Review the sample grouping CSV and contrast CSV before running differential expression.
  • Confirm processed count files and sample identifiers match the exported metadata.

Analysis Preparation Checklist

5/6 ready

Group labels reviewed

Needs review

Siftome proposed case and control labels, but no reviewer confirmation is stored yet.

Open the sample grouping CSV and confirm group labels before analysis.

Minimum sample count met

Ready

Both groups meet the minimum of 2 samples.

Confirm whether the cohort is large enough for the intended statistical analysis.

Processed counts available

Ready

Processed data availability is marked true in the GEO index.

Verify that downloaded processed files contain usable count or expression identifiers.

Ambiguous samples handled

Ready

No review-needed or unassigned samples are present in the proposed grouping.

Still scan the grouping table for biology-specific ambiguity.

Exclusion decisions recorded

Ready

No hard-excluded samples were detected by the current rules.

Record any manual exclusions in the downstream analysis notes.

Source links preserved

Ready

The dataset and sample accessions can be linked back to GEO.

Keep GEO dataset and sample links with exported metadata.

Bioinformatician Review

Standard analyst review

Proceed only after the analyst confirms grouping, exclusions, and source files.

No expert-review triggers were detected by Siftome.

Why This Is Ranked Here

Patient tissue tumor-vs-normal
Not suitable Dataset does not meet the current suitability threshold.

Score Components

  • relevance 100% Disease or condition metadata normalized. Organism normalized. Assay type normalized. Tissue metadata normalized.
  • comparison suitability 0% Case and control sample groups detected: breast cancer vs normal tissue. No excluded sample type flags detected. Tumor/normal design boosted for colorectal tumor-vs-normal tissue triage. Patient tissue or biopsy specimens boosted for tissue comparison triage. Non-colorectal cancer context downgraded for colorectal tumor-vs-normal tissue ranking.
  • metadata quality 100% Sample source clarity: All samples have source metadata and clear GSE/GSM accessions. Group clarity: Rule-based grouping found both case and control samples. Disease clarity: Disease or condition metadata normalized. Tissue clarity: Tissue metadata normalized. Treatment clarity: No unclear treatment split detected in the sample metadata. Replicate clarity: No pooled sample or technical replicate flags detected. Data availability clarity: Dataset-level processed or raw data availability is explicit.
  • data availability 100% Processed data available. Raw data available.
  • overall 34% Weighted score: 30% relevance, 30% comparison suitability, 25% metadata quality, 15% data availability. Overall score capped because comparison suitability is weak for the selected search intent. Overall score capped because tumor/normal grouping is from a non-colorectal cancer context.

Derived Classifications

  • Organism Homo sapiens Organism remains rule-derived: Homo sapiens.
  • Assay bulk RNA-seq Assay remains rule-derived: bulk RNA-seq.
  • Study design Tumor vs unmatched normal Study design remains rule-derived: Tumor vs unmatched normal.
  • Specimen/source Tissue Specimen/source remains rule-derived: Tissue.
  • Likely case group breast cancer 16 samples
  • Likely control group normal tissue 34 samples

Warnings

No ranking warnings are active.

Intent Interpretation

  • Active intent Patient tissue tumor-vs-normal Ranks human colorectal tissue or biopsy cohorts where tumor samples can be compared with normal controls.
  • Organism expectation Homo sapiens Dataset organism is interpreted as Homo sapiens.
  • Assay expectation bulk RNA-seq Dataset assay is interpreted as bulk RNA-seq.
  • Specimen assumption patient tissue or biopsy Derived specimen/source is Tissue.
  • Control-group assumption matched normal, adjacent normal, paired normal, healthy tissue control, or otherwise normal tissue control Derived study design is Tumor vs unmatched normal; likely groups are breast cancer vs normal tissue.
  • Score caps Applied when matching conditions are present non-human datasets stay below the primary recommendation band, missing colorectal/colon/rectal/CRC context stays below the primary recommendation band, biofluid and model-system datasets cannot reach Recommended by default, microarray and secondary assays are capped unless explicitly enabled, or small cohorts are capped below high-confidence recommendations
  • Warning rules 0 active warnings missing or unclear control group, unclear disease context, unclear tissue source, mixed sample types, model-system markers, secondary assay context, missing processed data, or small cohort size
  • Downgrade or exclusion reason Downgraded disease context: not a colorectal/GI cancer cohort. Derived from current-intent ranking reasons and warnings.

Applied Review Decisions

No active review decisions affect this ranking.

Ranking Facts

  • Recommendation Not suitable Dataset does not meet the current suitability threshold.
  • Supporting fact Tumor vs unmatched normal · Tissue · suitability 0%. Contributed to match or upgrade evidence.
  • Supporting fact Prioritized assay: bulk RNA-seq is the active assay expectation. Contributed to match or upgrade evidence.
  • Supporting fact Downgraded disease context: not a colorectal/GI cancer cohort. Contributed to match or upgrade evidence.
  • Supporting fact Processed data is available for downstream review. Contributed to match or upgrade evidence.
  • Caution fact Non-colorectal cancer context downgraded for colorectal tumor-vs-normal tissue ranking. Contributed to downgrade or manual-review evidence.
  • Caution fact Missing or unclear metadata: Treatment clarity: No unclear treatment split detected in the sample metadata. Contributed to downgrade or manual-review evidence.
  • Caution fact Overall score capped because comparison suitability is weak for the selected search intent. Contributed to downgrade or manual-review evidence.
  • Caution fact Overall score capped because tumor/normal grouping is from a non-colorectal cancer context. Contributed to downgrade or manual-review evidence.
  • Caution fact Downgraded disease context: not a colorectal/GI cancer cohort. Contributed to downgrade or manual-review evidence.
  • Caution fact Comparison suitability score is below the Phase 1 recommended threshold. Contributed to downgrade or manual-review evidence.

Manual Corrections

0 active

Source Evidence

4 sources

GEO

Primary source

Original dataset metadata, sample metadata, source links, and GEO data availability flags.

Dataset accession
GSE123762
Sample records
50 GSM samples
  • GEO has priority for original metadata under the Phase 3J source rules.
  • Processed data: available.
  • Raw data: available.
  • No external source conflict is present in the current runtime data.

recount3

Not imported

Planned trusted source for processed count availability.

GEO accession
GSE123762
  • No recount3 project identifier has been imported for this dataset.
  • Once imported, recount3 has priority for processed count availability.
  • The recount3 source filter excludes this dataset until that linkage exists.
No recount3 sync data available.

Expression Atlas

Not imported

Planned source for curated expression experiment links.

GEO accession
GSE123762
  • No Expression Atlas experiment identifier has been imported for this dataset.
  • Once imported, Expression Atlas has priority for curated expression experiment links.
  • The Expression Atlas source filter excludes this dataset until that linkage exists.
No Expression Atlas sync data available.

PubMed

Unavailable

Publication context when PubMed identifiers are already known.

GEO accession
GSE123762
  • No PubMed identifier is present in the current runtime metadata.
  • No live PubMed search is performed from the dataset detail page.
No publication identifier imported.

Dataset Feedback

0 stored

Original GEO Metadata

dataset_accession: GSE123762
dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq]
organism: Homo sapiens
assay_type: bulk RNA-seq
processed_data_available: true
raw_data_available: true
submission_date: 2018-12-13
last_update_date: 2021-01-26
organization_name: Flinders University
department: College of Medicine and Public Health
public_date: 2021-01-18
experiment_types: Expression profiling by high throughput sequencing
platforms: GPL16791 Illumina HiSeq 2500 (Homo sapiens)
sub_series: Not available
bioproject: PRJNA509777
supplementary_files: XLSX: GSE123762_Invasive_breast_cancer_E_v_ED_normalised_expression_RPKM.xlsx; XLSX: GSE123762_Normal_breast_E_v_ED_combined_expression_RPKM.xlsx
series_type: SubSeries

Why It Matched

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.

Why It May Not Be Suitable

  • Non-colorectal cancer context downgraded for colorectal tumor-vs-normal tissue ranking.
  • Missing or unclear metadata: Treatment clarity: No unclear treatment split detected in the sample metadata.
  • Overall score capped because comparison suitability is weak for the selected search intent.
  • Overall score capped because tumor/normal grouping is from a non-colorectal cancer context.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Comparison suitability score is below the Phase 1 recommended threshold.

Warnings

No warnings

Normalized Fields

104 fields
Field Value Source Origin Confidence Evidence Reason
assay_type bulk RNA-seq dataset GSE123762 Runtime Siftome inference GEO:dataset:GSE123762:dc3ea8136d311f487774b182acdb6a07036df09e6b3b4468a59a0e35c067ae97 high confidence bulk rna-seq dataset_accession: GSE123762 dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA... keyword match keyword match: bulk rna-seq
disease breast cancer dataset GSE123762 Runtime Siftome inference GEO:dataset:GSE123762:dc3ea8136d311f487774b182acdb6a07036df09e6b3b4468a59a0e35c067ae97 high confidence breast cancer dataset_accession: GSE123762 dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510975 Runtime Siftome inference GEO:sample:GSM3510975:1a26c7622530f8052c94c1b0690074b1a471d1b63bf04a697e9bacbb44cf0f15 high confidence breast cancer sample_accession: GSM3510975 sample_title: TH1-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510976 Runtime Siftome inference GEO:sample:GSM3510976:aeb96adc4b378a1b8427df0eb75bf93c53cd8cec108baefa329ff9323bef4693 high confidence breast cancer sample_accession: GSM3510976 sample_title: TH2-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510977 Runtime Siftome inference GEO:sample:GSM3510977:cfb4be5bd074977c2e620243bd9959e6b8406cb023826790970ea7c5c7e58fef high confidence breast cancer sample_accession: GSM3510977 sample_title: TH3-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510978 Runtime Siftome inference GEO:sample:GSM3510978:6b354386116ba767158418ecca8a595fc7a9751e0df7791307610d45cc1c5341 high confidence breast cancer sample_accession: GSM3510978 sample_title: TH4-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510979 Runtime Siftome inference GEO:sample:GSM3510979:f030f1c7477ef9cab7b0909c4385ffad8b8426b26716c68d2c72c75eeb094509 high confidence breast cancer sample_accession: GSM3510979 sample_title: TH5-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510980 Runtime Siftome inference GEO:sample:GSM3510980:a89c1918aa52b1ef58c8027c0ecd0ee332c83bccf357cb7e3666ca7af4426e01 high confidence breast cancer sample_accession: GSM3510980 sample_title: TH6-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510981 Runtime Siftome inference GEO:sample:GSM3510981:bb84a330f201d19e92058e6363437e84bc620843dddd6ec02f218bcabfd6a437 high confidence breast cancer sample_accession: GSM3510981 sample_title: TH7-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510982 Runtime Siftome inference GEO:sample:GSM3510982:389f203074f8fbf1cff743cbb65f9419ae48fe30aed96455d1422027399ec0ae high confidence breast cancer sample_accession: GSM3510982 sample_title: TH8-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510983 Runtime Siftome inference GEO:sample:GSM3510983:51337ce2df8a2e2c846e01907839e54bac6b75c7c11c5d70c63e55f17e0bce4e high confidence breast cancer sample_accession: GSM3510983 sample_title: TH1-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 1; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510984 Runtime Siftome inference GEO:sample:GSM3510984:1fdc14f3dff8fc7a5e00cf3c31b0b184121ed69dbd404707161526b87506f94c high confidence breast cancer sample_accession: GSM3510984 sample_title: TH2-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 2; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510985 Runtime Siftome inference GEO:sample:GSM3510985:5cdad0f4fec9ffea65506d6b5d4b131e48b711f0849ce4e93c07e45882da0102 high confidence breast cancer sample_accession: GSM3510985 sample_title: TH3-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 3; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510986 Runtime Siftome inference GEO:sample:GSM3510986:06e9ad2f594ea279436fce88c87be5d4ae2acf6919a54f4215ba377a5aa4514d high confidence breast cancer sample_accession: GSM3510986 sample_title: TH4-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 4; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510987 Runtime Siftome inference GEO:sample:GSM3510987:5d236db7d852aced8345c8c87d057054a75da65fed972004baf0d915b3120134 high confidence breast cancer sample_accession: GSM3510987 sample_title: TH5-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 5; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510988 Runtime Siftome inference GEO:sample:GSM3510988:bcd1672be04d9aab1f24683ef255542e76a47da32fa7fb0f3ea47cab27a6c8a2 high confidence breast cancer sample_accession: GSM3510988 sample_title: TH6-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 6; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510989 Runtime Siftome inference GEO:sample:GSM3510989:0184484a5783ca10fa81a1ae01c1a7dadff8199a0d16041d39443126a9f764d0 high confidence breast cancer sample_accession: GSM3510989 sample_title: TH7-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 7; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary disease match: breast cancer
disease breast cancer sample GSM3510990 Runtime Siftome inference GEO:sample:GSM3510990:a7093eb93b7e3d3cb47608e2c1c606c0e8769106240eaee03d537ddca131504e high confidence breast cancer sample_accession: GSM3510990 sample_title: TH8-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 8; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary disease match: breast cancer
organism Homo sapiens dataset GSE123762 Runtime Siftome inference GEO:dataset:GSE123762:dc3ea8136d311f487774b182acdb6a07036df09e6b3b4468a59a0e35c067ae97 high confidence homo sapiens dataset_accession: GSE123762 dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA... keyword match keyword match: homo sapiens
sample_type normal tissue sample GSM3510991 Runtime Siftome inference GEO:sample:GSM3510991:745b40edc71730ced095f815b3f5314c0488aa7912a95f3ff12ac70d7bb56e0d low confidence normal sample_accession: GSM3510991 sample_title: TH-81 E source_name: Normal breast_E2 characteristics: patient id: 81; tissue type: Normal breast; treatment: E2 TH-81 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3510992 Runtime Siftome inference GEO:sample:GSM3510992:61e90d6b1270abca6a6ad01f9045e9a16477a9c86d22c8599a59d775ed085122 low confidence normal sample_accession: GSM3510992 sample_title: TH-82 E source_name: Normal breast_E2 characteristics: patient id: 82; tissue type: Normal breast; treatment: E2 TH-82 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3510993 Runtime Siftome inference GEO:sample:GSM3510993:14a73cee32ebcc3352d9df9f155afa93a603ea6cc11d02e855e8c5490caa7ecc low confidence normal sample_accession: GSM3510993 sample_title: TH-83 E source_name: Normal breast_E2 characteristics: patient id: 83; tissue type: Normal breast; treatment: E2 TH-83 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3510994 Runtime Siftome inference GEO:sample:GSM3510994:f08aeaadc6adf052767025024b5e22ea668960f4684deb66baa73c96630931ec low confidence normal sample_accession: GSM3510994 sample_title: TH-84 E source_name: Normal breast_E2 characteristics: patient id: 84; tissue type: Normal breast; treatment: E2 TH-84 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3510995 Runtime Siftome inference GEO:sample:GSM3510995:4f3584b592745a3c942dbbc79db8a8a8265514e9abd824683351a65b0bda9f84 low confidence normal sample_accession: GSM3510995 sample_title: TH-85 E source_name: Normal breast_E2 characteristics: patient id: 85; tissue type: Normal breast; treatment: E2 TH-85 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3510996 Runtime Siftome inference GEO:sample:GSM3510996:01114f14516c0146993c21efe2e289db8d562317781449c6c56cb91e71053e33 low confidence normal sample_accession: GSM3510996 sample_title: TH-86 E source_name: Normal breast_E2 characteristics: patient id: 86; tissue type: Normal breast; treatment: E2 TH-86 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3510997 Runtime Siftome inference GEO:sample:GSM3510997:d4524d7e33204efeb9b43dd9d8c559fdba84d24d4022b093d87e543e6c7b419d low confidence normal sample_accession: GSM3510997 sample_title: TH-87 E source_name: Normal breast_E2 characteristics: patient id: 87; tissue type: Normal breast; treatment: E2 TH-87 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3510998 Runtime Siftome inference GEO:sample:GSM3510998:61d45fba383b0b6106451014049748190e4b7177fda5893221a964a216398e84 low confidence normal sample_accession: GSM3510998 sample_title: TH-88 E source_name: Normal breast_E2 characteristics: patient id: 88; tissue type: Normal breast; treatment: E2 TH-88 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3510999 Runtime Siftome inference GEO:sample:GSM3510999:cac5753de8961a7076b277ac931646a2dd1a43de308d0ad57042a500c3e3364f low confidence normal sample_accession: GSM3510999 sample_title: TH-89 E source_name: Normal breast_E2 characteristics: patient id: 89; tissue type: Normal breast; treatment: E2 TH-89 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511000 Runtime Siftome inference GEO:sample:GSM3511000:2277f5bced21f29a92dd47337a4ea85561c0fe757177ff9eb5759ea3cf7ee319 low confidence normal sample_accession: GSM3511000 sample_title: TH-101 E source_name: Normal breast_E2 characteristics: patient id: 101; tissue type: Normal breast; treatment: E2 TH-101 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511001 Runtime Siftome inference GEO:sample:GSM3511001:0a1b2f0ddcc8b1286c4c8bcebd436ec43705092d0899dd4297665c9d90bdd734 low confidence normal sample_accession: GSM3511001 sample_title: TH-102 E source_name: Normal breast_E2 characteristics: patient id: 102; tissue type: Normal breast; treatment: E2 TH-102 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511002 Runtime Siftome inference GEO:sample:GSM3511002:682dbc7dd96b0fdbd025ddb9b5e03a006c6b36566ae742038f7910c2b4a1e76d low confidence normal sample_accession: GSM3511002 sample_title: TH-103 E source_name: Normal breast_E2 characteristics: patient id: 103; tissue type: Normal breast; treatment: E2 TH-103 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511003 Runtime Siftome inference GEO:sample:GSM3511003:0f151b803b270c13287efcf4539ae1a27322c6d5ceb722ff21e840aa84db3880 low confidence normal sample_accession: GSM3511003 sample_title: TH-104 E source_name: Normal breast_E2 characteristics: patient id: 104; tissue type: Normal breast; treatment: E2 TH-104 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511004 Runtime Siftome inference GEO:sample:GSM3511004:ef1dd6fdf7221a8163cd0a3d7c49d5d1d17ee95f5750bab3e994f4227e8d4edd low confidence normal sample_accession: GSM3511004 sample_title: TH-105 E source_name: Normal breast_E2 characteristics: patient id: 105; tissue type: Normal breast; treatment: E2 TH-105 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511005 Runtime Siftome inference GEO:sample:GSM3511005:868907eb885cfec26906888c5a8423e0e233ca29eb5d7f30ca6fd18f8de44007 low confidence normal sample_accession: GSM3511005 sample_title: TH-106 E source_name: Normal breast_E2 characteristics: patient id: 106; tissue type: Normal breast; treatment: E2 TH-106 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511006 Runtime Siftome inference GEO:sample:GSM3511006:a209571ba2b46f23d54839afc6e9dfe12fc184024c05a9926d78c8aa03a8901c low confidence normal sample_accession: GSM3511006 sample_title: TH-107 E source_name: Normal breast_E2 characteristics: patient id: 107; tissue type: Normal breast; treatment: E2 TH-107 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511007 Runtime Siftome inference GEO:sample:GSM3511007:dbd2129107d32f6dab2ecec9c07b2a2a46f5ab31e02e91b13f9e7067b26e5932 low confidence normal sample_accession: GSM3511007 sample_title: TH-108 E source_name: Normal breast_E2 characteristics: patient id: 108; tissue type: Normal breast; treatment: E2 TH-108 E controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511008 Runtime Siftome inference GEO:sample:GSM3511008:b0d7aed84c54365ec971033fb664a592b143c0d31cc65bca11047e2f54f2d2f9 low confidence normal sample_accession: GSM3511008 sample_title: TH-81 ED source_name: Normal breast_E2+DHT characteristics: patient id: 81; tissue type: Normal breast; treatment: E2+DHT TH-81 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511009 Runtime Siftome inference GEO:sample:GSM3511009:e7391b6a4bb43115c7034b34ed7f43f08f2e50c2c34e66429c4d5c42d06bf8c2 low confidence normal sample_accession: GSM3511009 sample_title: TH-82 ED source_name: Normal breast_E2+DHT characteristics: patient id: 82; tissue type: Normal breast; treatment: E2+DHT TH-82 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511010 Runtime Siftome inference GEO:sample:GSM3511010:4ff44e567accb7ddb48db8c52dad690945ceb1ee6fe01f36e32e7316c45eba59 low confidence normal sample_accession: GSM3511010 sample_title: TH-83 ED source_name: Normal breast_E2+DHT characteristics: patient id: 83; tissue type: Normal breast; treatment: E2+DHT TH-83 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511011 Runtime Siftome inference GEO:sample:GSM3511011:122886a3f6b0f516acef2a1ddc888023647d1549ca1b46aa7cb96120848176db low confidence normal sample_accession: GSM3511011 sample_title: TH-84 ED source_name: Normal breast_E2+DHT characteristics: patient id: 84; tissue type: Normal breast; treatment: E2+DHT TH-84 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511012 Runtime Siftome inference GEO:sample:GSM3511012:a42f4dae1462f7176fbbb9924e8a126445fbe5d5e11332a097bebaa17adaacea low confidence normal sample_accession: GSM3511012 sample_title: TH-85 ED source_name: Normal breast_E2+DHT characteristics: patient id: 85; tissue type: Normal breast; treatment: E2+DHT TH-85 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511013 Runtime Siftome inference GEO:sample:GSM3511013:b63e2bad2bf0f9c8d0b66a5a1c15afe5db4e4432521ee8e52d7e0dcd5b4d42d6 low confidence normal sample_accession: GSM3511013 sample_title: TH-86 ED source_name: Normal breast_E2+DHT characteristics: patient id: 86; tissue type: Normal breast; treatment: E2+DHT TH-86 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511014 Runtime Siftome inference GEO:sample:GSM3511014:31453bcaef963cfe0d44a547c4c7e58d2e677441524aa20fe87f008ed115b7f7 low confidence normal sample_accession: GSM3511014 sample_title: TH-87 ED source_name: Normal breast_E2+DHT characteristics: patient id: 87; tissue type: Normal breast; treatment: E2+DHT TH-87 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511015 Runtime Siftome inference GEO:sample:GSM3511015:51db0429c679b8bc612e2236dcfd06c369d779e4378c81481fa97634db96257e low confidence normal sample_accession: GSM3511015 sample_title: TH-88 ED source_name: Normal breast_E2+DHT characteristics: patient id: 88; tissue type: Normal breast; treatment: E2+DHT TH-88 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511016 Runtime Siftome inference GEO:sample:GSM3511016:62531c0ec810698c4f206893e0441c9291398eea350c65f5554721cd2c721954 low confidence normal sample_accession: GSM3511016 sample_title: TH-89 ED source_name: Normal breast_E2+DHT characteristics: patient id: 89; tissue type: Normal breast; treatment: E2+DHT TH-89 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511017 Runtime Siftome inference GEO:sample:GSM3511017:d9e25f8c8a55d65f07a7870cc63c5d2d2f4f9f9d293ed25cc2e0dbd30771b83e low confidence normal sample_accession: GSM3511017 sample_title: TH-101 ED source_name: Normal breast_E2+DHT characteristics: patient id: 101; tissue type: Normal breast; treatment: E2+DHT TH-101 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511018 Runtime Siftome inference GEO:sample:GSM3511018:451a599f1717d5d5f923ef6e1f3ee652c00613b847420c5652f1d7600d8d252f low confidence normal sample_accession: GSM3511018 sample_title: TH-102 ED source_name: Normal breast_E2+DHT characteristics: patient id: 102; tissue type: Normal breast; treatment: E2+DHT TH-102 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511019 Runtime Siftome inference GEO:sample:GSM3511019:f2a8c09ee3b266d1ec72193b6e1fac81caac40a723b9409045558f0d0b282efe low confidence normal sample_accession: GSM3511019 sample_title: TH-103 ED source_name: Normal breast_E2+DHT characteristics: patient id: 103; tissue type: Normal breast; treatment: E2+DHT TH-103 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511020 Runtime Siftome inference GEO:sample:GSM3511020:452296fad96cf1e52ab393bb06da28ad9feec651c3603639d1090cf29c435a2d low confidence normal sample_accession: GSM3511020 sample_title: TH-104 ED source_name: Normal breast_E2+DHT characteristics: patient id: 104; tissue type: Normal breast; treatment: E2+DHT TH-104 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511021 Runtime Siftome inference GEO:sample:GSM3511021:a68a6f92dc07357e6b58b5b4ccc012d434ff8c38f3f7085eee47740fd3c3367e low confidence normal sample_accession: GSM3511021 sample_title: TH-105 ED source_name: Normal breast_E2+DHT characteristics: patient id: 105; tissue type: Normal breast; treatment: E2+DHT TH-105 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511022 Runtime Siftome inference GEO:sample:GSM3511022:f3d3161eacf2622aed9311175b889e17c2020264eb8ce51447aaa588f3ac1cd4 low confidence normal sample_accession: GSM3511022 sample_title: TH-106 ED source_name: Normal breast_E2+DHT characteristics: patient id: 106; tissue type: Normal breast; treatment: E2+DHT TH-106 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511023 Runtime Siftome inference GEO:sample:GSM3511023:bfcc665272b8cc7acf81b709e56deb6aae82c5e84266aefadc2a1d9a951e1868 low confidence normal sample_accession: GSM3511023 sample_title: TH-107 ED source_name: Normal breast_E2+DHT characteristics: patient id: 107; tissue type: Normal breast; treatment: E2+DHT TH-107 ED controlled vocabulary controlled vocabulary sample type match: normal
sample_type normal tissue sample GSM3511024 Runtime Siftome inference GEO:sample:GSM3511024:130259956a92d9187048aecf6660b7a1550a5f88a4487f20226c0b5f67500fef low confidence normal sample_accession: GSM3511024 sample_title: TH-108 ED source_name: Normal breast_E2+DHT characteristics: patient id: 108; tissue type: Normal breast; treatment: E2+DHT TH-108 ED controlled vocabulary controlled vocabulary sample type match: normal
tissue breast dataset GSE123762 Runtime Siftome inference GEO:dataset:GSE123762:dc3ea8136d311f487774b182acdb6a07036df09e6b3b4468a59a0e35c067ae97 low confidence breast dataset_accession: GSE123762 dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510975 Runtime Siftome inference GEO:sample:GSM3510975:1a26c7622530f8052c94c1b0690074b1a471d1b63bf04a697e9bacbb44cf0f15 low confidence breast sample_accession: GSM3510975 sample_title: TH1-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510976 Runtime Siftome inference GEO:sample:GSM3510976:aeb96adc4b378a1b8427df0eb75bf93c53cd8cec108baefa329ff9323bef4693 low confidence breast sample_accession: GSM3510976 sample_title: TH2-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510977 Runtime Siftome inference GEO:sample:GSM3510977:cfb4be5bd074977c2e620243bd9959e6b8406cb023826790970ea7c5c7e58fef low confidence breast sample_accession: GSM3510977 sample_title: TH3-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510978 Runtime Siftome inference GEO:sample:GSM3510978:6b354386116ba767158418ecca8a595fc7a9751e0df7791307610d45cc1c5341 low confidence breast sample_accession: GSM3510978 sample_title: TH4-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510979 Runtime Siftome inference GEO:sample:GSM3510979:f030f1c7477ef9cab7b0909c4385ffad8b8426b26716c68d2c72c75eeb094509 low confidence breast sample_accession: GSM3510979 sample_title: TH5-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510980 Runtime Siftome inference GEO:sample:GSM3510980:a89c1918aa52b1ef58c8027c0ecd0ee332c83bccf357cb7e3666ca7af4426e01 low confidence breast sample_accession: GSM3510980 sample_title: TH6-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510981 Runtime Siftome inference GEO:sample:GSM3510981:bb84a330f201d19e92058e6363437e84bc620843dddd6ec02f218bcabfd6a437 low confidence breast sample_accession: GSM3510981 sample_title: TH7-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510982 Runtime Siftome inference GEO:sample:GSM3510982:389f203074f8fbf1cff743cbb65f9419ae48fe30aed96455d1422027399ec0ae low confidence breast sample_accession: GSM3510982 sample_title: TH8-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510983 Runtime Siftome inference GEO:sample:GSM3510983:51337ce2df8a2e2c846e01907839e54bac6b75c7c11c5d70c63e55f17e0bce4e low confidence breast sample_accession: GSM3510983 sample_title: TH1-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 1; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510984 Runtime Siftome inference GEO:sample:GSM3510984:1fdc14f3dff8fc7a5e00cf3c31b0b184121ed69dbd404707161526b87506f94c low confidence breast sample_accession: GSM3510984 sample_title: TH2-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 2; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510985 Runtime Siftome inference GEO:sample:GSM3510985:5cdad0f4fec9ffea65506d6b5d4b131e48b711f0849ce4e93c07e45882da0102 low confidence breast sample_accession: GSM3510985 sample_title: TH3-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 3; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510986 Runtime Siftome inference GEO:sample:GSM3510986:06e9ad2f594ea279436fce88c87be5d4ae2acf6919a54f4215ba377a5aa4514d low confidence breast sample_accession: GSM3510986 sample_title: TH4-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 4; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510987 Runtime Siftome inference GEO:sample:GSM3510987:5d236db7d852aced8345c8c87d057054a75da65fed972004baf0d915b3120134 low confidence breast sample_accession: GSM3510987 sample_title: TH5-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 5; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510988 Runtime Siftome inference GEO:sample:GSM3510988:bcd1672be04d9aab1f24683ef255542e76a47da32fa7fb0f3ea47cab27a6c8a2 low confidence breast sample_accession: GSM3510988 sample_title: TH6-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 6; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510989 Runtime Siftome inference GEO:sample:GSM3510989:0184484a5783ca10fa81a1ae01c1a7dadff8199a0d16041d39443126a9f764d0 low confidence breast sample_accession: GSM3510989 sample_title: TH7-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 7; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510990 Runtime Siftome inference GEO:sample:GSM3510990:a7093eb93b7e3d3cb47608e2c1c606c0e8769106240eaee03d537ddca131504e low confidence breast sample_accession: GSM3510990 sample_title: TH8-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 8; tissue type: ER+ invasive breast cancer; treatme... controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510991 Runtime Siftome inference GEO:sample:GSM3510991:745b40edc71730ced095f815b3f5314c0488aa7912a95f3ff12ac70d7bb56e0d low confidence breast sample_accession: GSM3510991 sample_title: TH-81 E source_name: Normal breast_E2 characteristics: patient id: 81; tissue type: Normal breast; treatment: E2 TH-81 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510992 Runtime Siftome inference GEO:sample:GSM3510992:61e90d6b1270abca6a6ad01f9045e9a16477a9c86d22c8599a59d775ed085122 low confidence breast sample_accession: GSM3510992 sample_title: TH-82 E source_name: Normal breast_E2 characteristics: patient id: 82; tissue type: Normal breast; treatment: E2 TH-82 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510993 Runtime Siftome inference GEO:sample:GSM3510993:14a73cee32ebcc3352d9df9f155afa93a603ea6cc11d02e855e8c5490caa7ecc low confidence breast sample_accession: GSM3510993 sample_title: TH-83 E source_name: Normal breast_E2 characteristics: patient id: 83; tissue type: Normal breast; treatment: E2 TH-83 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510994 Runtime Siftome inference GEO:sample:GSM3510994:f08aeaadc6adf052767025024b5e22ea668960f4684deb66baa73c96630931ec low confidence breast sample_accession: GSM3510994 sample_title: TH-84 E source_name: Normal breast_E2 characteristics: patient id: 84; tissue type: Normal breast; treatment: E2 TH-84 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510995 Runtime Siftome inference GEO:sample:GSM3510995:4f3584b592745a3c942dbbc79db8a8a8265514e9abd824683351a65b0bda9f84 low confidence breast sample_accession: GSM3510995 sample_title: TH-85 E source_name: Normal breast_E2 characteristics: patient id: 85; tissue type: Normal breast; treatment: E2 TH-85 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510996 Runtime Siftome inference GEO:sample:GSM3510996:01114f14516c0146993c21efe2e289db8d562317781449c6c56cb91e71053e33 low confidence breast sample_accession: GSM3510996 sample_title: TH-86 E source_name: Normal breast_E2 characteristics: patient id: 86; tissue type: Normal breast; treatment: E2 TH-86 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510997 Runtime Siftome inference GEO:sample:GSM3510997:d4524d7e33204efeb9b43dd9d8c559fdba84d24d4022b093d87e543e6c7b419d low confidence breast sample_accession: GSM3510997 sample_title: TH-87 E source_name: Normal breast_E2 characteristics: patient id: 87; tissue type: Normal breast; treatment: E2 TH-87 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510998 Runtime Siftome inference GEO:sample:GSM3510998:61d45fba383b0b6106451014049748190e4b7177fda5893221a964a216398e84 low confidence breast sample_accession: GSM3510998 sample_title: TH-88 E source_name: Normal breast_E2 characteristics: patient id: 88; tissue type: Normal breast; treatment: E2 TH-88 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3510999 Runtime Siftome inference GEO:sample:GSM3510999:cac5753de8961a7076b277ac931646a2dd1a43de308d0ad57042a500c3e3364f low confidence breast sample_accession: GSM3510999 sample_title: TH-89 E source_name: Normal breast_E2 characteristics: patient id: 89; tissue type: Normal breast; treatment: E2 TH-89 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511000 Runtime Siftome inference GEO:sample:GSM3511000:2277f5bced21f29a92dd47337a4ea85561c0fe757177ff9eb5759ea3cf7ee319 low confidence breast sample_accession: GSM3511000 sample_title: TH-101 E source_name: Normal breast_E2 characteristics: patient id: 101; tissue type: Normal breast; treatment: E2 TH-101 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511001 Runtime Siftome inference GEO:sample:GSM3511001:0a1b2f0ddcc8b1286c4c8bcebd436ec43705092d0899dd4297665c9d90bdd734 low confidence breast sample_accession: GSM3511001 sample_title: TH-102 E source_name: Normal breast_E2 characteristics: patient id: 102; tissue type: Normal breast; treatment: E2 TH-102 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511002 Runtime Siftome inference GEO:sample:GSM3511002:682dbc7dd96b0fdbd025ddb9b5e03a006c6b36566ae742038f7910c2b4a1e76d low confidence breast sample_accession: GSM3511002 sample_title: TH-103 E source_name: Normal breast_E2 characteristics: patient id: 103; tissue type: Normal breast; treatment: E2 TH-103 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511003 Runtime Siftome inference GEO:sample:GSM3511003:0f151b803b270c13287efcf4539ae1a27322c6d5ceb722ff21e840aa84db3880 low confidence breast sample_accession: GSM3511003 sample_title: TH-104 E source_name: Normal breast_E2 characteristics: patient id: 104; tissue type: Normal breast; treatment: E2 TH-104 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511004 Runtime Siftome inference GEO:sample:GSM3511004:ef1dd6fdf7221a8163cd0a3d7c49d5d1d17ee95f5750bab3e994f4227e8d4edd low confidence breast sample_accession: GSM3511004 sample_title: TH-105 E source_name: Normal breast_E2 characteristics: patient id: 105; tissue type: Normal breast; treatment: E2 TH-105 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511005 Runtime Siftome inference GEO:sample:GSM3511005:868907eb885cfec26906888c5a8423e0e233ca29eb5d7f30ca6fd18f8de44007 low confidence breast sample_accession: GSM3511005 sample_title: TH-106 E source_name: Normal breast_E2 characteristics: patient id: 106; tissue type: Normal breast; treatment: E2 TH-106 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511006 Runtime Siftome inference GEO:sample:GSM3511006:a209571ba2b46f23d54839afc6e9dfe12fc184024c05a9926d78c8aa03a8901c low confidence breast sample_accession: GSM3511006 sample_title: TH-107 E source_name: Normal breast_E2 characteristics: patient id: 107; tissue type: Normal breast; treatment: E2 TH-107 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511007 Runtime Siftome inference GEO:sample:GSM3511007:dbd2129107d32f6dab2ecec9c07b2a2a46f5ab31e02e91b13f9e7067b26e5932 low confidence breast sample_accession: GSM3511007 sample_title: TH-108 E source_name: Normal breast_E2 characteristics: patient id: 108; tissue type: Normal breast; treatment: E2 TH-108 E controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511008 Runtime Siftome inference GEO:sample:GSM3511008:b0d7aed84c54365ec971033fb664a592b143c0d31cc65bca11047e2f54f2d2f9 low confidence breast sample_accession: GSM3511008 sample_title: TH-81 ED source_name: Normal breast_E2+DHT characteristics: patient id: 81; tissue type: Normal breast; treatment: E2+DHT TH-81 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511009 Runtime Siftome inference GEO:sample:GSM3511009:e7391b6a4bb43115c7034b34ed7f43f08f2e50c2c34e66429c4d5c42d06bf8c2 low confidence breast sample_accession: GSM3511009 sample_title: TH-82 ED source_name: Normal breast_E2+DHT characteristics: patient id: 82; tissue type: Normal breast; treatment: E2+DHT TH-82 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511010 Runtime Siftome inference GEO:sample:GSM3511010:4ff44e567accb7ddb48db8c52dad690945ceb1ee6fe01f36e32e7316c45eba59 low confidence breast sample_accession: GSM3511010 sample_title: TH-83 ED source_name: Normal breast_E2+DHT characteristics: patient id: 83; tissue type: Normal breast; treatment: E2+DHT TH-83 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511011 Runtime Siftome inference GEO:sample:GSM3511011:122886a3f6b0f516acef2a1ddc888023647d1549ca1b46aa7cb96120848176db low confidence breast sample_accession: GSM3511011 sample_title: TH-84 ED source_name: Normal breast_E2+DHT characteristics: patient id: 84; tissue type: Normal breast; treatment: E2+DHT TH-84 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511012 Runtime Siftome inference GEO:sample:GSM3511012:a42f4dae1462f7176fbbb9924e8a126445fbe5d5e11332a097bebaa17adaacea low confidence breast sample_accession: GSM3511012 sample_title: TH-85 ED source_name: Normal breast_E2+DHT characteristics: patient id: 85; tissue type: Normal breast; treatment: E2+DHT TH-85 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511013 Runtime Siftome inference GEO:sample:GSM3511013:b63e2bad2bf0f9c8d0b66a5a1c15afe5db4e4432521ee8e52d7e0dcd5b4d42d6 low confidence breast sample_accession: GSM3511013 sample_title: TH-86 ED source_name: Normal breast_E2+DHT characteristics: patient id: 86; tissue type: Normal breast; treatment: E2+DHT TH-86 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511014 Runtime Siftome inference GEO:sample:GSM3511014:31453bcaef963cfe0d44a547c4c7e58d2e677441524aa20fe87f008ed115b7f7 low confidence breast sample_accession: GSM3511014 sample_title: TH-87 ED source_name: Normal breast_E2+DHT characteristics: patient id: 87; tissue type: Normal breast; treatment: E2+DHT TH-87 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511015 Runtime Siftome inference GEO:sample:GSM3511015:51db0429c679b8bc612e2236dcfd06c369d779e4378c81481fa97634db96257e low confidence breast sample_accession: GSM3511015 sample_title: TH-88 ED source_name: Normal breast_E2+DHT characteristics: patient id: 88; tissue type: Normal breast; treatment: E2+DHT TH-88 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511016 Runtime Siftome inference GEO:sample:GSM3511016:62531c0ec810698c4f206893e0441c9291398eea350c65f5554721cd2c721954 low confidence breast sample_accession: GSM3511016 sample_title: TH-89 ED source_name: Normal breast_E2+DHT characteristics: patient id: 89; tissue type: Normal breast; treatment: E2+DHT TH-89 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511017 Runtime Siftome inference GEO:sample:GSM3511017:d9e25f8c8a55d65f07a7870cc63c5d2d2f4f9f9d293ed25cc2e0dbd30771b83e low confidence breast sample_accession: GSM3511017 sample_title: TH-101 ED source_name: Normal breast_E2+DHT characteristics: patient id: 101; tissue type: Normal breast; treatment: E2+DHT TH-101 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511018 Runtime Siftome inference GEO:sample:GSM3511018:451a599f1717d5d5f923ef6e1f3ee652c00613b847420c5652f1d7600d8d252f low confidence breast sample_accession: GSM3511018 sample_title: TH-102 ED source_name: Normal breast_E2+DHT characteristics: patient id: 102; tissue type: Normal breast; treatment: E2+DHT TH-102 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511019 Runtime Siftome inference GEO:sample:GSM3511019:f2a8c09ee3b266d1ec72193b6e1fac81caac40a723b9409045558f0d0b282efe low confidence breast sample_accession: GSM3511019 sample_title: TH-103 ED source_name: Normal breast_E2+DHT characteristics: patient id: 103; tissue type: Normal breast; treatment: E2+DHT TH-103 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511020 Runtime Siftome inference GEO:sample:GSM3511020:452296fad96cf1e52ab393bb06da28ad9feec651c3603639d1090cf29c435a2d low confidence breast sample_accession: GSM3511020 sample_title: TH-104 ED source_name: Normal breast_E2+DHT characteristics: patient id: 104; tissue type: Normal breast; treatment: E2+DHT TH-104 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511021 Runtime Siftome inference GEO:sample:GSM3511021:a68a6f92dc07357e6b58b5b4ccc012d434ff8c38f3f7085eee47740fd3c3367e low confidence breast sample_accession: GSM3511021 sample_title: TH-105 ED source_name: Normal breast_E2+DHT characteristics: patient id: 105; tissue type: Normal breast; treatment: E2+DHT TH-105 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511022 Runtime Siftome inference GEO:sample:GSM3511022:f3d3161eacf2622aed9311175b889e17c2020264eb8ce51447aaa588f3ac1cd4 low confidence breast sample_accession: GSM3511022 sample_title: TH-106 ED source_name: Normal breast_E2+DHT characteristics: patient id: 106; tissue type: Normal breast; treatment: E2+DHT TH-106 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511023 Runtime Siftome inference GEO:sample:GSM3511023:bfcc665272b8cc7acf81b709e56deb6aae82c5e84266aefadc2a1d9a951e1868 low confidence breast sample_accession: GSM3511023 sample_title: TH-107 ED source_name: Normal breast_E2+DHT characteristics: patient id: 107; tissue type: Normal breast; treatment: E2+DHT TH-107 ED controlled vocabulary controlled vocabulary tissue match: breast
tissue breast sample GSM3511024 Runtime Siftome inference GEO:sample:GSM3511024:130259956a92d9187048aecf6660b7a1550a5f88a4487f20226c0b5f67500fef low confidence breast sample_accession: GSM3511024 sample_title: TH-108 ED source_name: Normal breast_E2+DHT characteristics: patient id: 108; tissue type: Normal breast; treatment: E2+DHT TH-108 ED controlled vocabulary controlled vocabulary tissue match: breast

Sample Group Preview

Possible case samples

Samples currently treated as the comparison case group.

16
  • GSM3510975 TH1-E breast cancer Case marker detected. ER+ invasive breast cancer_E2 patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510976 TH2-E breast cancer Case marker detected. ER+ invasive breast cancer_E2 patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510977 TH3-E breast cancer Case marker detected. ER+ invasive breast cancer_E2 patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510978 TH4-E breast cancer Case marker detected. ER+ invasive breast cancer_E2 patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510979 TH5-E breast cancer Case marker detected. ER+ invasive breast cancer_E2 patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510980 TH6-E breast cancer Case marker detected. ER+ invasive breast cancer_E2 patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510981 TH7-E breast cancer Case marker detected. ER+ invasive breast cancer_E2 patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510982 TH8-E breast cancer Case marker detected. ER+ invasive breast cancer_E2 patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510983 TH1-ED breast cancer Case marker detected. ER+ invasive breast cancer_E2+DHT patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510984 TH2-ED breast cancer Case marker detected. ER+ invasive breast cancer_E2+DHT patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510985 TH3-ED breast cancer Case marker detected. ER+ invasive breast cancer_E2+DHT patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510986 TH4-ED breast cancer Case marker detected. ER+ invasive breast cancer_E2+DHT patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510987 TH5-ED breast cancer Case marker detected. ER+ invasive breast cancer_E2+DHT patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510988 TH6-ED breast cancer Case marker detected. ER+ invasive breast cancer_E2+DHT patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510989 TH7-ED breast cancer Case marker detected. ER+ invasive breast cancer_E2+DHT patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510990 TH8-ED breast cancer Case marker detected. ER+ invasive breast cancer_E2+DHT patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E2+DHT

Possible control samples

Samples currently treated as controls or baseline.

34
  • GSM3510991 TH-81 E normal tissue Control marker detected. Normal breast_E2 patient id: 81; tissue type: Normal breast; treatment: E2
  • GSM3510992 TH-82 E normal tissue Control marker detected. Normal breast_E2 patient id: 82; tissue type: Normal breast; treatment: E2
  • GSM3510993 TH-83 E normal tissue Control marker detected. Normal breast_E2 patient id: 83; tissue type: Normal breast; treatment: E2
  • GSM3510994 TH-84 E normal tissue Control marker detected. Normal breast_E2 patient id: 84; tissue type: Normal breast; treatment: E2
  • GSM3510995 TH-85 E normal tissue Control marker detected. Normal breast_E2 patient id: 85; tissue type: Normal breast; treatment: E2
  • GSM3510996 TH-86 E normal tissue Control marker detected. Normal breast_E2 patient id: 86; tissue type: Normal breast; treatment: E2
  • GSM3510997 TH-87 E normal tissue Control marker detected. Normal breast_E2 patient id: 87; tissue type: Normal breast; treatment: E2
  • GSM3510998 TH-88 E normal tissue Control marker detected. Normal breast_E2 patient id: 88; tissue type: Normal breast; treatment: E2
  • GSM3510999 TH-89 E normal tissue Control marker detected. Normal breast_E2 patient id: 89; tissue type: Normal breast; treatment: E2
  • GSM3511000 TH-101 E normal tissue Control marker detected. Normal breast_E2 patient id: 101; tissue type: Normal breast; treatment: E2
  • GSM3511001 TH-102 E normal tissue Control marker detected. Normal breast_E2 patient id: 102; tissue type: Normal breast; treatment: E2
  • GSM3511002 TH-103 E normal tissue Control marker detected. Normal breast_E2 patient id: 103; tissue type: Normal breast; treatment: E2
  • GSM3511003 TH-104 E normal tissue Control marker detected. Normal breast_E2 patient id: 104; tissue type: Normal breast; treatment: E2
  • GSM3511004 TH-105 E normal tissue Control marker detected. Normal breast_E2 patient id: 105; tissue type: Normal breast; treatment: E2
  • GSM3511005 TH-106 E normal tissue Control marker detected. Normal breast_E2 patient id: 106; tissue type: Normal breast; treatment: E2
  • GSM3511006 TH-107 E normal tissue Control marker detected. Normal breast_E2 patient id: 107; tissue type: Normal breast; treatment: E2
  • GSM3511007 TH-108 E normal tissue Control marker detected. Normal breast_E2 patient id: 108; tissue type: Normal breast; treatment: E2
  • GSM3511008 TH-81 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 81; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511009 TH-82 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 82; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511010 TH-83 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 83; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511011 TH-84 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 84; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511012 TH-85 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 85; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511013 TH-86 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 86; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511014 TH-87 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 87; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511015 TH-88 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 88; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511016 TH-89 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 89; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511017 TH-101 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 101; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511018 TH-102 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 102; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511019 TH-103 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 103; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511020 TH-104 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 104; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511021 TH-105 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 105; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511022 TH-106 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 106; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511023 TH-107 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 107; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511024 TH-108 ED normal tissue Control marker detected. Normal breast_E2+DHT patient id: 108; tissue type: Normal breast; treatment: E2+DHT

Unassigned samples

Samples with no explicit case or control marker.

0

No samples

Excluded samples

Samples excluded from grouping by hard exclusion rules.

0

No samples

Ambiguous samples

Samples that need manual review before trusting grouping.

0

No samples

Metadata Quality Components

Detected Sample Groups

breast cancer

16 samples
  • GSM3510975 TH1-E ER+ invasive breast cancer_E2 patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510976 TH2-E ER+ invasive breast cancer_E2 patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510977 TH3-E ER+ invasive breast cancer_E2 patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510978 TH4-E ER+ invasive breast cancer_E2 patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510979 TH5-E ER+ invasive breast cancer_E2 patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510980 TH6-E ER+ invasive breast cancer_E2 patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510981 TH7-E ER+ invasive breast cancer_E2 patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510982 TH8-E ER+ invasive breast cancer_E2 patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E2
  • GSM3510983 TH1-ED ER+ invasive breast cancer_E2+DHT patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510984 TH2-ED ER+ invasive breast cancer_E2+DHT patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510985 TH3-ED ER+ invasive breast cancer_E2+DHT patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510986 TH4-ED ER+ invasive breast cancer_E2+DHT patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510987 TH5-ED ER+ invasive breast cancer_E2+DHT patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510988 TH6-ED ER+ invasive breast cancer_E2+DHT patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510989 TH7-ED ER+ invasive breast cancer_E2+DHT patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
  • GSM3510990 TH8-ED ER+ invasive breast cancer_E2+DHT patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E2+DHT

normal tissue

34 samples
  • GSM3510991 TH-81 E Normal breast_E2 patient id: 81; tissue type: Normal breast; treatment: E2
  • GSM3510992 TH-82 E Normal breast_E2 patient id: 82; tissue type: Normal breast; treatment: E2
  • GSM3510993 TH-83 E Normal breast_E2 patient id: 83; tissue type: Normal breast; treatment: E2
  • GSM3510994 TH-84 E Normal breast_E2 patient id: 84; tissue type: Normal breast; treatment: E2
  • GSM3510995 TH-85 E Normal breast_E2 patient id: 85; tissue type: Normal breast; treatment: E2
  • GSM3510996 TH-86 E Normal breast_E2 patient id: 86; tissue type: Normal breast; treatment: E2
  • GSM3510997 TH-87 E Normal breast_E2 patient id: 87; tissue type: Normal breast; treatment: E2
  • GSM3510998 TH-88 E Normal breast_E2 patient id: 88; tissue type: Normal breast; treatment: E2
  • GSM3510999 TH-89 E Normal breast_E2 patient id: 89; tissue type: Normal breast; treatment: E2
  • GSM3511000 TH-101 E Normal breast_E2 patient id: 101; tissue type: Normal breast; treatment: E2
  • GSM3511001 TH-102 E Normal breast_E2 patient id: 102; tissue type: Normal breast; treatment: E2
  • GSM3511002 TH-103 E Normal breast_E2 patient id: 103; tissue type: Normal breast; treatment: E2
  • GSM3511003 TH-104 E Normal breast_E2 patient id: 104; tissue type: Normal breast; treatment: E2
  • GSM3511004 TH-105 E Normal breast_E2 patient id: 105; tissue type: Normal breast; treatment: E2
  • GSM3511005 TH-106 E Normal breast_E2 patient id: 106; tissue type: Normal breast; treatment: E2
  • GSM3511006 TH-107 E Normal breast_E2 patient id: 107; tissue type: Normal breast; treatment: E2
  • GSM3511007 TH-108 E Normal breast_E2 patient id: 108; tissue type: Normal breast; treatment: E2
  • GSM3511008 TH-81 ED Normal breast_E2+DHT patient id: 81; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511009 TH-82 ED Normal breast_E2+DHT patient id: 82; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511010 TH-83 ED Normal breast_E2+DHT patient id: 83; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511011 TH-84 ED Normal breast_E2+DHT patient id: 84; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511012 TH-85 ED Normal breast_E2+DHT patient id: 85; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511013 TH-86 ED Normal breast_E2+DHT patient id: 86; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511014 TH-87 ED Normal breast_E2+DHT patient id: 87; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511015 TH-88 ED Normal breast_E2+DHT patient id: 88; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511016 TH-89 ED Normal breast_E2+DHT patient id: 89; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511017 TH-101 ED Normal breast_E2+DHT patient id: 101; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511018 TH-102 ED Normal breast_E2+DHT patient id: 102; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511019 TH-103 ED Normal breast_E2+DHT patient id: 103; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511020 TH-104 ED Normal breast_E2+DHT patient id: 104; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511021 TH-105 ED Normal breast_E2+DHT patient id: 105; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511022 TH-106 ED Normal breast_E2+DHT patient id: 106; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511023 TH-107 ED Normal breast_E2+DHT patient id: 107; tissue type: Normal breast; treatment: E2+DHT
  • GSM3511024 TH-108 ED Normal breast_E2+DHT patient id: 108; tissue type: Normal breast; treatment: E2+DHT

Score Breakdown

100%

relevance

  • Disease or condition metadata normalized.
  • Organism normalized.
  • Assay type normalized.
  • Tissue metadata normalized.
0%

comparison suitability

  • Case and control sample groups detected: breast cancer vs normal tissue.
  • No excluded sample type flags detected.
  • Tumor/normal design boosted for colorectal tumor-vs-normal tissue triage.
  • Patient tissue or biopsy specimens boosted for tissue comparison triage.
  • Non-colorectal cancer context downgraded for colorectal tumor-vs-normal tissue ranking.
100%

metadata quality

  • Sample source clarity: All samples have source metadata and clear GSE/GSM accessions.
  • Group clarity: Rule-based grouping found both case and control samples.
  • Disease clarity: Disease or condition metadata normalized.
  • Tissue clarity: Tissue metadata normalized.
  • Treatment clarity: No unclear treatment split detected in the sample metadata.
  • Replicate clarity: No pooled sample or technical replicate flags detected.
  • Data availability clarity: Dataset-level processed or raw data availability is explicit.
100%

data availability

  • Processed data available.
  • Raw data available.
34%

overall

  • Weighted score: 30% relevance, 30% comparison suitability, 25% metadata quality, 15% data availability.
  • Overall score capped because comparison suitability is weak for the selected search intent.
  • Overall score capped because tumor/normal grouping is from a non-colorectal cancer context.

Sample Links

50 samples

Review Audit Trail

0 decisions

No review decisions have been stored for this dataset.